[Hub]/) : Traits : Arm fat percentage (right) : ← →

chr17:41,555,474-42,998,534

Best TWAS P=6.9e-14 · Best GWAS P=8.39e-14 conditioned to 0.138

Associated models

#	Study	Tissue	Gene	h2	eQTL R2	model	# weights	model R2	model R2 P	eQTL GWAS Z	TWAS Z	TWAS P	Top SNP corr	PP3	PP4	joint
24	The Cancer Genome Atlas	Bladder Urothelial Carcinoma	C17orf65	0.03	0.00	blup	37	0.01	2.3e-02	6.7	-7.5	6.9e-14	-0.92	0.02	0.86	TRUE
34	The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	ASB16	0.04	0.04	lasso	4	0.03	1.8e-04	7.5	-7.4	1.4e-13	-0.99	0.00	0.99	FALSE
27	The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	ASB16	0.02	0.02	blup	39	0.02	3.8e-03	7.3	-7.3	2.8e-13	-0.90	0.02	0.52	FALSE
41	The Cancer Genome Atlas	Thyroid Carcinoma	C17orf65	0.03	0.03	lasso	7	0.03	3.8e-04	6.7	-7.1	1.2e-12	-0.94	0.02	0.95	FALSE
40	The Cancer Genome Atlas	Testicular Germ Cell Tumors	C17orf65	0.07	0.02	blup	38	0.04	1.1e-02	6.2	-7.1	1.4e-12	-0.86	0.03	0.17	FALSE
28	The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	C17orf65	0.03	0.01	lasso	10	0.02	3.6e-03	6.7	-7.0	1.8e-12	-0.82	0.03	0.87	FALSE
9	GTEx	Heart Left Ventricle	RP5-882C2.2	0.14	0.08	lasso	5	0.10	8.1e-06	6.7	-6.9	3.7e-12	-0.83	0.06	0.92	FALSE
29	The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	ASB16	0.02	0.03	blup	40	0.03	1.3e-04	6.3	-6.9	3.9e-12	-0.89	0.13	0.84	FALSE
38	The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	C17orf65	0.09	0.09	enet	8	0.08	2.9e-04	6.3	-6.9	4.1e-12	-0.91	0.03	0.92	FALSE
26	The Cancer Genome Atlas	Colon Adenocarcinoma	C17orf65	0.05	0.06	blup	38	0.05	4.2e-04	5.2	-6.9	6.5e-12	-0.90	0.11	0.74	FALSE
19	GTEx	Thyroid	RP5-882C2.2	0.10	0.07	lasso	3	0.07	2.9e-06	6.7	-6.9	6.8e-12	-0.85	0.03	0.96	FALSE
22	GTEx	Whole Blood	ASB16-AS1	0.14	0.05	lasso	6	0.04	3.1e-04	6.7	-6.8	7.4e-12	-0.90	0.15	0.84	FALSE
18	GTEx	Testis	ASB16-AS1	0.35	0.25	lasso	5	0.23	1.0e-10	6.7	-6.8	9.8e-12	-0.90	0.07	0.93	FALSE
5	GTEx	Cells Transformed fibroblasts	ASB16	0.14	0.14	lasso	3	0.12	2.0e-09	6.7	-6.7	1.9e-11	-0.89	0.18	0.82	FALSE
7	GTEx	Esophagus Mucosa	ASB16	0.10	0.10	lasso	4	0.08	8.2e-06	6.7	-6.7	2.0e-11	-0.89	0.09	0.90	FALSE
20	GTEx	Thyroid	ASB16-AS1	0.14	0.06	lasso	2	0.04	5.4e-04	6.7	-6.7	2.0e-11	-0.89	0.10	0.83	FALSE
25	The Cancer Genome Atlas	Colon Adenocarcinoma	ASB16	0.05	0.06	blup	40	0.05	4.6e-04	6.5	-6.7	2.1e-11	-0.90	0.04	0.87	FALSE
13	GTEx	Nerve Tibial	ASB16	0.12	0.07	lasso	5	0.07	7.5e-06	6.7	-6.6	3.1e-11	-0.87	0.18	0.82	FALSE
35	The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	C17orf65	0.07	0.05	lasso	6	0.05	3.1e-06	6.7	-6.6	3.9e-11	-0.88	0.02	0.98	FALSE
32	The Cancer Genome Atlas	Brain Lower Grade Glioma	C17orf65	0.04	0.04	blup	37	0.03	1.4e-04	6.7	-6.6	5.5e-11	-0.86	0.17	0.80	FALSE
6	GTEx	Cells Transformed fibroblasts	ASB16-AS1	0.17	0.17	lasso	4	0.16	2.3e-12	6.7	-6.5	7.9e-11	-0.83	0.21	0.79	FALSE
17	GTEx	Skin Sun Exposed Lower leg	ASB16-AS1	0.13	0.09	lasso	5	0.07	2.7e-06	6.3	-6.3	2.5e-10	-0.87	0.29	0.71	FALSE
36	The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	C17orf65	0.04	0.03	blup	39	0.03	2.7e-03	7.3	-6.3	2.6e-10	-0.89	0.01	0.92	FALSE
14	GTEx	Nerve Tibial	ASB16-AS1	0.17	0.15	lasso	5	0.16	1.4e-11	6.7	-6.3	2.8e-10	-0.85	0.24	0.76	FALSE
31	The Cancer Genome Atlas	Brain Lower Grade Glioma	ASB16	0.03	0.03	lasso	3	0.03	3.2e-04	6.2	-6.3	2.9e-10	-0.85	0.14	0.73	FALSE
4	GTEx	Breast Mammary Tissue (Female)	ASB16-AS1	0.08	0.04	lasso	2	0.06	7.9e-03	6.1	-6.3	3.4e-10	-0.85	0.06	0.50	FALSE
3	GTEx	Adipose Visceral Omentum	ASB16-AS1	0.14	0.12	lasso	5	0.10	9.8e-06	6.1	-6.3	3.9e-10	-0.84	0.39	0.56	FALSE
1	CommonMind	Brain Pre-frontal Cortex	C17orf65	0.07	0.06	enet	15	0.07	4.5e-09	6.7	-6.1	9.5e-10	-0.84	0.30	0.70	FALSE
2	GTEx	Adipose Subcutaneous	ASB16-AS1	0.12	0.05	enet	16	0.05	3.7e-05	6.7	-6.1	1.1e-09	-0.75	0.11	0.72	FALSE
8	GTEx	Esophagus Mucosa	ASB16-AS1	0.11	0.08	enet	16	0.07	3.7e-05	4.9	-6.0	1.5e-09	-0.78	0.25	0.74	FALSE
39	The Cancer Genome Atlas	Skin Cutaneous Melanoma	C17orf65	0.15	0.05	blup	37	0.09	1.7e-03	6.7	-6.0	1.5e-09	-0.83	0.02	0.63	FALSE
37	The Cancer Genome Atlas	Pancreatic Adenocarcinoma	C17orf65	0.09	0.02	blup	38	0.04	8.0e-03	6.7	-6.0	2.0e-09	-0.86	0.01	0.60	FALSE
33	The Cancer Genome Atlas	Lung Adenocarcinoma	ASB16	0.02	0.02	lasso	4	0.01	6.3e-03	6.7	-6.0	2.6e-09	-0.83	0.05	0.48	FALSE
10	GTEx	Lung	ASB16	0.09	0.09	enet	15	0.07	3.4e-06	6.7	-5.9	4.6e-09	-0.81	0.09	0.91	FALSE
15	GTEx	Pituitary	ASB16-AS1	0.19	0.17	lasso	4	0.22	3.8e-06	4.1	-5.9	4.6e-09	-0.79	0.15	0.66	FALSE
21	GTEx	Whole Blood	ASB16	0.11	0.03	enet	24	0.03	6.3e-04	6.3	-5.8	8.2e-09	-0.63	0.14	0.51	FALSE
23	The Cancer Genome Atlas	Bladder Urothelial Carcinoma	ASB16	0.03	0.01	enet	4	0.02	1.2e-02	6.3	-5.8	8.9e-09	-0.82	0.02	0.47	FALSE
12	GTEx	Muscle Skeletal	ASB16	0.07	0.06	lasso	3	0.06	2.9e-06	5.2	5.7	1.1e-08	0.80	0.10	0.90	FALSE
11	GTEx	Lung	ASB16-AS1	0.15	0.12	enet	19	0.12	1.5e-09	6.7	-5.6	1.7e-08	-0.79	0.14	0.86	FALSE
30	The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	C17orf65	0.05	0.05	lasso	2	0.05	2.5e-06	5.2	-5.5	3.1e-08	-0.78	0.14	0.85	FALSE
16	GTEx	Skin Sun Exposed Lower leg	ASB16	0.11	0.03	enet	9	0.02	4.3e-03	6.3	-5.3	1.2e-07	-0.74	0.23	0.47	FALSE